Mark Pruzanski
Overview
Mark Pruzanski received an average of $5M in total compensation, including $583K in salary, at Intercept Pharmaceuticals from 2011 to 2020.
2020Intercept PharmaceuticalsPresident and Chief Executive Officer
2019Intercept PharmaceuticalsPresident and Chief Executive Officer
2018Intercept PharmaceuticalsPresident and Chief Executive Officer
2017Intercept PharmaceuticalsPresident and Chief Executive Officer
2016Intercept PharmaceuticalsPresident and Chief Executive Officer
2015Intercept PharmaceuticalsChief Executive Officer and President
2014Intercept PharmaceuticalsChief Executive Officer and President
2013Intercept PharmaceuticalsChief Executive Officer and President
2012Intercept PharmaceuticalsChief Executive Officer and President
2011Intercept PharmaceuticalsChief Executive Officer and President
Source: SEC filings on April 27, 2021, April 29, 2020, April 30, 2019, April 27, 2018, June 20, 2016, and April 12, 2013.
Related executives
We found 16 more executives who work or worked at Intercept Pharmaceuticals.
Jerome Durso
Intercept Pharmaceuticals
Chief Executive Officer
Jared Freedberg
Intercept Pharmaceuticals
General Counsel
Michelle Berrey
Intercept Pharmaceuticals
Chief Medical Officer
Gail Cawkwell
Intercept Pharmaceuticals
SVP Medical Affairs, Safety & Pharmacovigilance
Andrew Saik
Intercept Pharmaceuticals
Chief Financial Officer
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
Rocco Venezia
Intercept Pharmaceuticals
Chief Financial Officer
Richard Kim
Intercept Pharmaceuticals